Skip to main content
. 2021 Jan 28;296:100343. doi: 10.1016/j.jbc.2021.100343

Table 1.

Missense mutations in mature SPINK1 identified in patients with CP (CP carriers) and individuals without CP (non-CP carriers)

Exon Nucleotide change Amino acid change CP carriers reported Non-CP carriers reported Carrier frequency in gnomAD
Exon 3 c.101A>G p.N34S 1889 (238 hm) 402 (9 hm) 1.8%
Exon 3 c.110A>G p.N37S 3 0.04%
Exon 3 c.123G>C p.K41N 1 1 Not reported
Exon 3 c.126A>G p.I42M 1 0.006%
Exon 3 c.133C>T p.P45S 2 Not reported
Exon 3 c.137T>A p.V46D 1 Not reported
Exon 3 c.143G>A p.G48E 1 1 Not reported
Exon 3 c.150T>G p.D50E 1 0.0004%
Exon 3 c.160T>C p.Y54H 2 Not reported
Exon 3 c.163C>T p.P55S 50 (1 hm) 57 (1 hm) 0.9%
Exon 3 c.190A>G p.N64D 2 Not reported
Exon 3 c.193C>T p.R65W 1 0.003%
Exon 3 c.194G>A p.R65Q 6 (1 hm) 2 0.1%
Exon 4 c.198A>C p.K66N 2 0.023%
Exon 4 c.199C>T p.R67C 4 2 0.003%
Exon 4 c.200G>A p.R67H 15 1 0.32%
Exon 4 c.203A>G p.Q68R 1 0.02%
Exon 4 c.206C>T p.T69I 1 0.001%
Exon 4 c.236G>T p.C79F 1 Not reported

CP, chronic pancreatitis.

Missense variants in exon 1 that affect the secretory signal peptide were excluded. The emboldened variants with preserved secretion were analyzed in this study. The number of homozygous (hm) carriers within the total number is indicated in parenthesis. Data were obtained from the pancreasgenetics.org and gnomad.broadinstitute.org Web sites on July 9, 2020.